Surgical Innovations Group plc (AIM:SUN)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.4800
+0.0300 (6.67%)
May 8, 2026, 12:52 PM GMT

AIM:SUN Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11.611.9512.0111.349.13
Revenue Growth (YoY)
-2.87%-0.57%5.94%24.26%44.19%
Cost of Revenue
8.558.518.577.426
Gross Profit
3.053.443.453.923.13
Selling, General & Admin
-2.712.632.422.13
Research & Development
-1.151.11.160.97
Amortization of Goodwill & Intangibles
-0.210.280.230.4
Other Operating Expenses
3.78----
Operating Expenses
3.784.074.043.853.53
Operating Income
-0.73-0.64-0.590.07-0.4
Interest Expense
-0.07-0.1-0.13-0.1-0.13
EBT Excluding Unusual Items
-0.79-0.74-0.72-0.03-0.53
Asset Writedown
-0.15-1.16---
Other Unusual Items
--0.15-0.01-0.03-0.05
Pretax Income
-0.94-2.05-0.73-0.06-0.59
Income Tax Expense
-0.05-0.11-0.22-0.32-0.13
Net Income
-0.9-1.94-0.510.26-0.46
Net Income to Common
-0.9-1.94-0.510.26-0.46
Shares Outstanding (Basic)
895933933933937
Shares Outstanding (Diluted)
895933933936939
Shares Change (YoY)
-4.05%--0.33%-0.30%12.18%
EPS (Basic)
-0.00-0.00-0.000.00-0.00
EPS (Diluted)
-0.00-0.00-0.000.00-0.00
Free Cash Flow
0.51-0.140.12-0.17-0.65
Free Cash Flow Per Share
0.00----0.00
Gross Margin
26.31%28.77%28.70%34.59%34.31%
Operating Margin
-6.28%-5.34%-4.89%0.64%-4.41%
Profit Margin
-7.71%-16.27%-4.24%2.33%-5.00%
Free Cash Flow Margin
4.38%-1.18%0.97%-1.53%-7.07%
EBITDA
-0.5-0.37-0.340.24-0.14
EBITDA Margin
-4.33%-3.12%-2.85%2.12%-1.58%
D&A For EBITDA
0.230.270.250.170.26
EBIT
-0.73-0.64-0.590.07-0.4
EBIT Margin
-6.28%-5.34%-4.89%0.64%-4.41%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.